Variant report
Variant | esv2653196 |
---|---|
Chromosome Location | chr7:124975657-124977241 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190792469 | chr7:124975659-124975660 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs117681269 | chr7:124975686-124975687 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532697734 | chr7:124975707-124975708 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs201802614 | chr7:124975722-124975723 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs369405194 | chr7:124975727-124975728 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75907347 | chr7:124975736-124975737 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549252904 | chr7:124975873-124975874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538459937 | chr7:124975886-124975887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373782088 | chr7:124975914-124975915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs202108193 | chr7:124975927-124975928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs57733213 | chr7:124975928-124975929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377291788 | chr7:124975929-124975930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200117606 | chr7:124975930-124975931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372873675 | chr7:124975931-124975932 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35496796 | chr7:124975932-124975933 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs34276235 | chr7:124975934-124975935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34836626 | chr7:124975936-124975937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568253845 | chr7:124975938-124975939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201514204 | chr7:124975960-124975961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs534023653 | chr7:124975964-124975965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs71312858 | chr7:124975976-124975977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs34709434 | chr7:124975986-124975987 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73719376 | chr7:124975994-124975995 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs576783508 | chr7:124976008-124976009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545796645 | chr7:124976017-124976018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556398529 | chr7:124976018-124976019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs6467000 | chr7:124976039-124976040 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs542043837 | chr7:124976132-124976133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs561857139 | chr7:124976134-124976135 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564246267 | chr7:124976193-124976194 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566063714 | chr7:124976206-124976207 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541081867 | chr7:124976306-124976307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs17390435 | chr7:124976330-124976331 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs554326522 | chr7:124976344-124976345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532913620 | chr7:124976356-124976357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs148926466 | chr7:124976371-124976372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376005926 | chr7:124976374-124976375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113292659 | chr7:124976382-124976383 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571724309 | chr7:124976386-124976387 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs34756400 | chr7:124976411-124976412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537014318 | chr7:124976430-124976431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs192893660 | chr7:124976445-124976446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs537141671 | chr7:124976456-124976457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs139370264 | chr7:124976471-124976472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs371372737 | chr7:124976482-124976483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548419423 | chr7:124976526-124976527 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568265948 | chr7:124976563-124976564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374391241 | chr7:124976591-124976592 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs185395278 | chr7:124976610-124976611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs115636200 | chr7:124976612-124976613 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Epilepsy | 21635232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Autism | 20858243 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:124962000-124984400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr7:124975200-124977200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr7:124975200-124977600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr7:124975400-124976800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr7:124975400-124977600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr7:124975600-124975800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr7:124975600-124975800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr7:124975600-124976400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr7:124975600-124976600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
10 | chr7:124975600-124977400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr7:124975800-124976600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
12 | chr7:124975800-124976800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
13 | chr7:124976600-124977200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr7:124976800-124977200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr7:124977200-124978000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |